NDC 0002-4165 is a in the category. It is labeled and distributed by .
| Proprietary Name | NDC 0002-4165 |
| Marketing Category | / |
| Marketing Category | NDA |
| Application Number | NDA020815 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1998-01-06 |
| Marketing End Date | 2011-01-25 |
| Marketing Category | NDA |
| Application Number | NDA020815 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2009-08-06 |
| Marketing End Date | 2012-03-05 |
| Marketing Category | NDA |
| Application Number | NDA020815 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1998-01-06 |
| Marketing End Date | 2018-01-31 |
| Marketing Category | NDA |
| Application Number | NDA020815 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1998-01-06 |
| Marketing End Date | 2017-12-31 |
| Marketing Category | NDA |
| Application Number | NDA020815 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-06-10 |
| Marketing End Date | 2015-04-03 |
| Marketing Category | NDA |
| Application Number | NDA020815 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1998-01-06 |
| Marketing End Date | 2017-11-30 |
| Marketing Category | NDA |
| Application Number | NDA020815 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1998-01-06 |
| Marketing End Date | 2011-01-25 |